Kelly M. Brady
Chief Tech/Sci/R&D Officer bij SERES THERAPEUTICS, INC.
Profiel
Kelly M.
Brady is currently the Vice President-Clinical Operations at Seres Therapeutics, Inc. She previously worked as a Senior Director at Akebia Therapeutics, Inc. and as a Member-Operations Team at Osiris Therapeutics, Inc. Ms. Brady holds a graduate degree from The Johns Hopkins University and an undergraduate degree from Lafayette College.
Actieve functies van Kelly M. Brady
| Bedrijven | Functie | Begin |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-06-2018 |
Eerdere bekende functies van Kelly M. Brady
| Bedrijven | Functie | Einde |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Kelly M. Brady
| The Johns Hopkins University | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
